CJC-1295 is also not FDA-approved for anti-aging, muscle building, fat loss, or general wellness
"I find it difficult to imagine GLP-1 medications being prescribed solely for depression," Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California, tells SELF
It directly targets two of the biggest roadblocks people face: overwhelming cravings and a lack of energy
Aesth Plast Surg 49 , 63646371 (2025)
Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
